Head-to-head · WeighScore
NextMeds vs ShapeIn Rx
The verdict
NextMeds takes it — 66.3/100 to 60.4/100.
NextMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NextMeds | ShapeIn Rx |
|---|---|---|
| WeighScore | 66.3/100 | 60.4/100 |
| Grade | C | C |
| Scorecard rank | #191 | #323 |
| Semaglutide | $129/mo (plus a separate fee, compounded) | $199/mo (compounded) |
| Tirzepatide | $179/mo (plus a separate fee, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #191 · C
Strengths
- Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
- Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
- Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
- Free, no-obligation online assessment before you pay anything
Where it loses points
- Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
- Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
- A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Graded #323 · C
Strengths
- One of the few telehealth providers offering compounded liraglutide as a daily alternative to weekly injections
- Semaglutide is compounded with B12, and the combination is stated plainly
- Publishes a street address and a staffed phone line with hours
- States openly that telemedicine is limited to jurisdictions where its providers are licensed, rather than claiming all 50
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Advertises Trusted by 150k Americans and Excellent 4.8 with 150k happy customers, and neither figure is attributable to a verifiable review profile
- No state list is published, only a statement that coverage is limited and a note that partner pharmacies may operate in all 50 states
- The struck-through $199 next to $149 on the homepage reads as a discount but the two prices are different medications
- Claims No Hidden Fees and No Monthly Membership while the Terms state subscriptions automatically renew
- No compounding pharmacy is named, only US-Certified Pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.